Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021 · Science Immunology · 617 citations
https://doi.org/10.1126/sciimmunol.abl4340
O
Olivier Hermine
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.8K
Papers
64.6K
Citations
135
h-index
778
i10-index
Olivier Hermine is an academic researcher from Délégation Paris 5. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Mast cells and histamine & T-cell and Retrovirus Studies. The author has an h-index of 135, co-authored 1530 publications.
ORCID: 0000-0003-2574-3874Papers by this author
worksRituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
2017 · New England Journal of Medicine · 402 citations
https://doi.org/10.1056/nejmoa1701769
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
2016 · The Lancet · 390 citations
https://doi.org/10.1016/s0140-6736(16)00739-x
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
2022 · Nature Medicine · 355 citations
https://doi.org/10.1038/s41591-022-01969-y
TGF-β1 Prevents the Noncognate Maturation of Human Dendritic Langerhans Cells
1999 · The Journal of Immunology · 319 citations
https://doi.org/10.4049/jimmunol.162.8.4567
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
2017 · Journal of Allergy and Clinical Immunology · 304 citations
https://doi.org/10.1016/j.jaci.2016.12.978
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat